The Killer Immunoglobulin-Like Receptor (KIR) Group A Haplotype is Associated With Bronchiolitis Obliterans Syndrome After Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 9, 2008, Pages 995-1001

  Kwakkel van Erp, Johanna M ^a   van de Graaf, Ed A ^a   Paantjens, Annelieke W M ^a   van Ginkel, Walter G J ^a   Schellekens, Jennifer ^a   van Kessel, Diana A ^b   van den Bosch, Jules M M ^b   Otten, Henny G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FEMALE; GENE; HAPLOTYPE; HUMAN; KILLER IMMUNOGLOBULIN LIKE RECEPTOR GENE; KIR2DS5 GENE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; VIRUS REACTIVATION;

BRONCHIOLITIS OBLITERANS; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; FORCED EXPIRATORY VOLUME; GENOTYPE; GRAFT REJECTION; HOMOZYGOTE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; LUNG TRANSPLANTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; RECEPTORS, KIR; RECURRENCE;

EID: 50249155401     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.06.006     Document Type: Article

References (31)

1. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 8 (2006) 880-892
2. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 6 (2003) 665-673
3. Gould D.S., and Auchincloss H. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 20 2 (1999) 77-82
4. Côté I., Rogers N.J., and Lechler R.I. Allorecognition. Transfus Clin Biol 8 3 (2001) 318-323
5. Jiang S., Herrera O., and Lechler R.I. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr Opin Immunol 16 5 (2004) 550-557
6. Middleton D., Curran M., and Maxwell L. Natural killer cells and their receptors. Transplant Immunol 10 2-3 (2002) 147-164
7. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 3 (2005) 201-214
8. Anfossi N., Andre P., Guia S., Falk C.S., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25 2 (2006) 331-342
9. Huard B., and Fruh K. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur J Immunol 30 2 (2000) 509-515
10. Hsu K.C., Liu X.R., Selvakumar A., Mickelson E., O'Reilly R.J., and Dupont B. Killer Ig-like receptor haplotype analysis by gene content: Evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169 9 (2002) 5118-5129
11. Hsu K.C., Chida S., Dupont B., and Geraghty D.E. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 190 1 (2002) 40-52
12. Uhrberg M., Parham P., and Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54 4 (2002) 221-229
13. Kikuchi-Maki A., Yusa S., Catina T.L., and Campbell K.S. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 171 7 (2003) 3415-3425
14. Marsh S.G., Parham P., Dupont B., et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics 55 4 (2003) 220-226
15. Kroger N., Binder T., Zabelina T., et al. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-Cell depleted unrelated stem cell transplantation. Transplantation 82 8 (2006) 1024-1030
16. Cook M., Briggs D., Craddock C., et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 107 3 (2006) 1230-1232
17. De Santis D., Bishara A., Witt C.S., et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 65 6 (2005) 519-528
18. Fildes J.E., Yonan N., Tunstall K., et al. Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation. J Heart Lung Transplant 27 2 (2008) 203-207
19. Estenne M., and Hertz M.I. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 166 4 (2002) 440-444
20. Ruggeri L., Capanni M., Casucci M., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94 1 (1999) 333-339
21. Tran T.H., Mytilineos J., Scherer S., Laux G., Middleton D., and Opelz G. Analysis of KIR ligand incompatibility in human renal transplantation. Transplantation 80 8 (2005) 1121-1123
22. Kreijveld E., Van der Meer A., Tijssen H.J., Hilbrands L.B., and Joosten I. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Transplantation 84 8 (2007) 1045-1051
23. Kunert K., Seiler M., Mashreghi M.F., et al. KIR/HLA ligand incompatibility in kidney transplantation. Transplantation 84 11 (2007) 1527-1533
24. Marcenaro E., Dondero A., and Moretta A. Multi-directional cross-regulation of NK cell function during innate immune responses. Transplant Immunol 17 1 (2006) 16-19
25. Saeki H., Moore A.M., Brown M.J., and Hwang S.T. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162 5 (1999) 2472-2475
26. Sallusto F., Palermo B., Lenig D., et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29 5 (1999) 1617-1625
27. Holt P.G., Haining S., Nelson D.J., and Sedgwick J.D. Origin and steady-state turnover of class-Ii Mhc-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 153 1 (1994) 256-261
28. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., and Caligiuri M.A. NK cell and DC interactions. Trends Immunol 25 1 (2004) 47-52
29. Boehler A., and Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 22 6 (2003) 1007-1018
30. Martin M.P., Gao X.J., Lee J.H., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31 4 (2002) 429-434
31. Chen C., Busson M., Rocha V., et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 38 6 (2006) 437-444